Selected research
Industry Research
GMP-grade AAV Vector Manufacturing Service Industry Research Report 2026
Market perspective
The global GMP-grade AAV Vector Manufacturing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the GMP-grade AAV Vector Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the GMP-grade AAV Vector Manufacturing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the GMP-grade AAV Vector Manufacturing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of GMP-grade AAV Vector Manufacturing Service include Catalent, AGC Biologics, SK pharmteco, OXB, Forge Biologics, Viralgen, Andelyn Biosciences, Resilience and Advanced Therapies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global GMP-grade AAV Vector Manufacturing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to GMP-grade AAV Vector Manufacturing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
GMP-grade AAV Vector Manufacturing Service Market by Company
Catalent
AGC Biologics
SK pharmteco
OXB
Forge Biologics
Viralgen
Andelyn Biosciences
Resilience
Advanced Therapies
IDT Biologika
Matica Bio
Takara Bio
VectorBuilder
GenScript ProBio
PackGene Biotech
Thermo Fisher Scientific
Lonza
Charles River Laboratories
GMP-grade AAV Vector Manufacturing Service Segment by Type
GMP Drug Substance Manufacturing
GMP Drug Substance and Fill-Finish
End-to-End CMC and Manufacturing
GMP-grade AAV Vector Manufacturing Service Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Other
GMP-grade AAV Vector Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP-grade AAV Vector Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP-grade AAV Vector Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP-grade AAV Vector Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of GMP-grade AAV Vector Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- GMP Drug Substance Manufacturing
- GMP Drug Substance and Fill-Finish
- End-to-End CMC and Manufacturing
Applications
- Biotechnology Companies
- Pharmaceutical Companies
- Other
Companies covered
- Catalent
- AGC Biologics
- SK pharmteco
- OXB
- Forge Biologics
- Viralgen
- Andelyn Biosciences
- Resilience
- Advanced Therapies
- IDT Biologika
- Matica Bio
- Takara Bio
- VectorBuilder
- GenScript ProBio
- PackGene Biotech
- Thermo Fisher Scientific
- Lonza
- Charles River Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 GMP-grade AAV Vector Manufacturing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 GMP Drug Substance Manufacturing
- 2.2.3 GMP Drug Substance and Fill-Finish
- 2.2.4 End-to-End CMC and Manufacturing
- 2.3 GMP-grade AAV Vector Manufacturing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biotechnology Companies
- 2.3.3 Pharmaceutical Companies
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 GMP-grade AAV Vector Manufacturing Service Breakdown Data by Type
- 3.1 Global GMP-grade AAV Vector Manufacturing Service Historic Market Size by Type (2021-2026)
- 3.2 Global GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Type (2027-2032)
4 GMP-grade AAV Vector Manufacturing Service Breakdown Data by Application
- 4.1 Global GMP-grade AAV Vector Manufacturing Service Historic Market Size by Application (2021-2026)
- 4.2 Global GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global GMP-grade AAV Vector Manufacturing Service Market Perspective (2021-2032)
- 5.2 Global GMP-grade AAV Vector Manufacturing Service Growth Trends by Region
- 5.2.1 Global GMP-grade AAV Vector Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 GMP-grade AAV Vector Manufacturing Service Historic Market Size by Region (2021-2026)
- 5.2.3 GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Region (2027-2032)
- 5.3 GMP-grade AAV Vector Manufacturing Service Market Dynamics
- 5.3.1 GMP-grade AAV Vector Manufacturing Service Industry Trends
- 5.3.2 GMP-grade AAV Vector Manufacturing Service Market Drivers
- 5.3.3 GMP-grade AAV Vector Manufacturing Service Market Challenges
- 5.3.4 GMP-grade AAV Vector Manufacturing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top GMP-grade AAV Vector Manufacturing Service Players by Revenue
- 6.1.1 Global Top GMP-grade AAV Vector Manufacturing Service Players by Revenue (2021-2026)
- 6.1.2 Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global GMP-grade AAV Vector Manufacturing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of GMP-grade AAV Vector Manufacturing Service Head Office and Area Served
- 6.4 Global GMP-grade AAV Vector Manufacturing Service Players, Product Type & Application
- 6.5 Global GMP-grade AAV Vector Manufacturing Service Manufacturers Established Date
- 6.6 Global GMP-grade AAV Vector Manufacturing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America GMP-grade AAV Vector Manufacturing Service Market Size (2021-2032)
- 7.2 North America GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021-2026)
- 7.4 North America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe GMP-grade AAV Vector Manufacturing Service Market Size (2021-2032)
- 8.2 Europe GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021-2026)
- 8.4 Europe GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size (2021-2032)
- 9.2 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America GMP-grade AAV Vector Manufacturing Service Market Size (2021-2032)
- 10.2 South America GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021-2026)
- 10.4 South America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size (2021-2032)
- 11.2 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Catalent
- 12.1.1 Catalent Company Information
- 12.1.2 Catalent Business Overview
- 12.1.3 Catalent Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.1.4 Catalent GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.1.5 Catalent Recent Developments
- 12.2 AGC Biologics
- 12.2.1 AGC Biologics Company Information
- 12.2.2 AGC Biologics Business Overview
- 12.2.3 AGC Biologics Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.2.4 AGC Biologics GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.2.5 AGC Biologics Recent Developments
- 12.3 SK pharmteco
- 12.3.1 SK pharmteco Company Information
- 12.3.2 SK pharmteco Business Overview
- 12.3.3 SK pharmteco Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.3.4 SK pharmteco GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.3.5 SK pharmteco Recent Developments
- 12.4 OXB
- 12.4.1 OXB Company Information
- 12.4.2 OXB Business Overview
- 12.4.3 OXB Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.4.4 OXB GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.4.5 OXB Recent Developments
- 12.5 Forge Biologics
- 12.5.1 Forge Biologics Company Information
- 12.5.2 Forge Biologics Business Overview
- 12.5.3 Forge Biologics Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.5.4 Forge Biologics GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.5.5 Forge Biologics Recent Developments
- 12.6 Viralgen
- 12.6.1 Viralgen Company Information
- 12.6.2 Viralgen Business Overview
- 12.6.3 Viralgen Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.6.4 Viralgen GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.6.5 Viralgen Recent Developments
- 12.7 Andelyn Biosciences
- 12.7.1 Andelyn Biosciences Company Information
- 12.7.2 Andelyn Biosciences Business Overview
- 12.7.3 Andelyn Biosciences Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.7.4 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.7.5 Andelyn Biosciences Recent Developments
- 12.8 Resilience
- 12.8.1 Resilience Company Information
- 12.8.2 Resilience Business Overview
- 12.8.3 Resilience Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.8.4 Resilience GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.8.5 Resilience Recent Developments
- 12.9 Advanced Therapies
- 12.9.1 Advanced Therapies Company Information
- 12.9.2 Advanced Therapies Business Overview
- 12.9.3 Advanced Therapies Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.9.4 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.9.5 Advanced Therapies Recent Developments
- 12.10 IDT Biologika
- 12.10.1 IDT Biologika Company Information
- 12.10.2 IDT Biologika Business Overview
- 12.10.3 IDT Biologika Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.10.4 IDT Biologika GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.10.5 IDT Biologika Recent Developments
- 12.11 Matica Bio
- 12.11.1 Matica Bio Company Information
- 12.11.2 Matica Bio Business Overview
- 12.11.3 Matica Bio Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.11.4 Matica Bio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.11.5 Matica Bio Recent Developments
- 12.12 Takara Bio
- 12.12.1 Takara Bio Company Information
- 12.12.2 Takara Bio Business Overview
- 12.12.3 Takara Bio Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.12.4 Takara Bio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.12.5 Takara Bio Recent Developments
- 12.13 VectorBuilder
- 12.13.1 VectorBuilder Company Information
- 12.13.2 VectorBuilder Business Overview
- 12.13.3 VectorBuilder Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.13.4 VectorBuilder GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.13.5 VectorBuilder Recent Developments
- 12.14 GenScript ProBio
- 12.14.1 GenScript ProBio Company Information
- 12.14.2 GenScript ProBio Business Overview
- 12.14.3 GenScript ProBio Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.14.4 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.14.5 GenScript ProBio Recent Developments
- 12.15 PackGene Biotech
- 12.15.1 PackGene Biotech Company Information
- 12.15.2 PackGene Biotech Business Overview
- 12.15.3 PackGene Biotech Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.15.4 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.15.5 PackGene Biotech Recent Developments
- 12.16 Thermo Fisher Scientific
- 12.16.1 Thermo Fisher Scientific Company Information
- 12.16.2 Thermo Fisher Scientific Business Overview
- 12.16.3 Thermo Fisher Scientific Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.16.4 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.16.5 Thermo Fisher Scientific Recent Developments
- 12.17 Lonza
- 12.17.1 Lonza Company Information
- 12.17.2 Lonza Business Overview
- 12.17.3 Lonza Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.17.4 Lonza GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.17.5 Lonza Recent Developments
- 12.18 Charles River Laboratories
- 12.18.1 Charles River Laboratories Company Information
- 12.18.2 Charles River Laboratories Business Overview
- 12.18.3 Charles River Laboratories Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021-2026)
- 12.18.4 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 12.18.5 Charles River Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst